Latest News about KYMR
Recent news which mentions KYMR
Kymera Therapeutics's Return On Capital Employed Insights
February 27, 2023
Tickers
KYMR
From Benzinga
7 Perfect Presents to Gift Your 2023 Stock Portfolio
December 21, 2022
From InvestorPlace
Why Netcapital Shares Are Trading Lower By Over 33%? Here Are 50 Stocks Moving In Wednesday's Mid-Day Session
December 14, 2022
From Benzinga
These Biotech Stocks Are the Nasdaq's Big Wednesday Winners
December 14, 2022
From Motley Fool
Dear DS Stock Fans, Mark Your Calendars for Dec. 23
December 14, 2022
From InvestorPlace
Why Is SOFI Stock Up 7% Today?
December 14, 2022
From InvestorPlace
Dear CRKN Stock Fans, Mark Your Calendars for Dec. 22
December 14, 2022
From InvestorPlace
Why Is Kymera Therapeutics (KYMR) Stock Up 20% Today?
December 14, 2022
From InvestorPlace
REV Group, Avidity Biosciences And Some Other Big Stocks Moving Higher On Wednesday
December 14, 2022
From Benzinga
From Benzinga
US Stocks Higher Ahead Of Fed Decision
December 14, 2022
From Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
December 14, 2022
From Benzinga
JetBlue Airways, Pacira BioSciences And Some Other Big Stocks Moving Lower On Tuesday
December 13, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 6, 2022
December 06, 2022
From Benzinga
From Benzinga
What 4 Analyst Ratings Have To Say About Kymera Therapeutics
December 06, 2022
Tickers
KYMR
From Benzinga
Looking Into Kymera Therapeutics's Return On Capital Employed
November 22, 2022
Tickers
KYMR
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 8, 2022
November 08, 2022
From Benzinga
Important Biotech Catalysts For September 15, 2022 - End Of The Day Summary
September 15, 2022
From Benzinga
Kymera Gets Orphan Drug Status For Rare Blood Cancer Candidate
September 15, 2022
Tickers
KYMR
From Benzinga
Looking Into Kymera Therapeutics's Return On Capital Employed
September 02, 2022
Tickers
KYMR
From Benzinga
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 15, 2022
August 15, 2022
From Benzinga
During the second quarter, Kymera Therapeutics (KYMR) reported an 8-cent decline in earnings per share
August 12, 2022
Tickers
KYMR
From Best Stocks
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.